
Christopher Swift
About Christopher Swift
Christopher J. Swift, age 64, is Chairman (since Jan 5, 2015) and CEO (since Jul 1, 2014) of The Hartford (HIG), and has served on HIG’s board since 2014; he is also a director of Citizens Financial Group (since 2021) and sits on HIG’s Finance, Investment and Risk Management Committee (FIRMCo) . Under his leadership, 2024 was an “outstanding year” with net income ROE of 19.9%, core earnings ROE of 16.7%, and net income and core earnings of $3.1B ($10.35/$10.30 per diluted share) . The company reported 2024 revenues of $26.5B and delivered TSR performance that, on a fixed $100 base from 2019, reached $202 versus $201 for the peer index . Swift’s pay mix is highly performance-based (about 93% variable at target), with annual incentives tied to Compensation Core Earnings and long-term incentives focused on three-year Compensation Core ROE and relative TSR .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| The Hartford Insurance Group, Inc. | Executive VP & CFO | 2010–2014 | Led development of go-forward strategy, capital actions, and strategic investments . |
| The Hartford Insurance Group, Inc. | CEO | 2014–present | Executed strategy driving ROE and profitable growth; advanced digital/AI investments . |
| The Hartford Insurance Group, Inc. | Chairman | 2015–present | Board leadership, succession planning, and oversight of risk and innovation . |
| American International Group, Inc. | VP & CFO, Life & Retirement Services | 2003–2010 | Senior finance leadership in highly regulated insurance operations . |
| Conning Asset Management, General American Life | Executive Vice President | 1997–1999 | Asset management leadership supporting insurance investment performance . |
| KPMG LLP | Partner (1993–1997), Auditor (1983–1993) | 1983–1997 | Led Global Insurance Industry Practice; deep technical accounting expertise . |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| Citizens Financial Group, Inc. | Director | 2021–present | Public company board; no related-party transactions disclosed in 2024 . |
Fixed Compensation (2024)
| Component | Amount | Notes |
|---|---|---|
| Base Salary | $1,200,000 | Unchanged vs. 2023 . |
| Annual Incentive Target | $3,300,000 | Based on Compensation Core Earnings . |
| Annual Incentive Paid | $4,719,000 (143% of target) | Formulaic AIP funding at 143% based on $3.15B Compensation Core Earnings vs $2.84B target . |
| Perquisites (disclosed) | $268,215 | Includes personal aircraft use ($230,409), commuting, spouse attendance at business functions . |
Performance Compensation
Incentive Design and Outcomes
| Metric | Weighting | Target | Actual/Status | Payout | Vesting/Timing |
|---|---|---|---|---|---|
| Annual Incentive: Compensation Core Earnings | 100% (funding basis) | $2.84B (2024) | $3.15B (2024) | 143% of target (CEO award equals funding) | Cash awarded Feb 2025 . |
| PSUs 2024–2026: Compensation Core ROE | 2/3 of PSUs | 15.5% avg annual ROE (’24–’26) | In-progress | 0–200% curve; threshold at 80% of target | Performance period ends 12/31/2026 . |
| PSUs 2024–2026: Relative TSR vs 15 peers | 1/3 of PSUs | 55th percentile = 100%; 30th = 35%; 85th = 200% | In-progress | 0–200% curve | Performance period ends 12/31/2026 . |
| PSUs 2022–2024: Compensation Core ROE | 50% of PSUs | Curve: 10.8%/13.5%/16.2% → 35%/100%/200% | 16.3% achieved | 200% of target for ROE component | Vested 12/31/2024; certified 2/18/2025 . |
| PSUs 2022–2024: Relative TSR | 50% of PSUs | 55th percentile = 100% | 73rd percentile achieved | 160% of target for TSR component | Vested 12/31/2024; certified 2/18/2025 . |
| 2024 Stock Options | N/A | Exercise price $95.74 (2/27/2024) | Vest 1/3 per year, 10-year term | Market-dependent | Expire 2/27/2034 . |
2024 Grants Detail (Swift)
| Award | Grant Date | Threshold | Target | Max | Notes |
|---|---|---|---|---|---|
| Stock Options | 2/27/2024 | — | 116,414 options | — | Vest 1/3 annually; 10-year term; exercise price $95.74 . |
| PSUs | 2/27/2024 | 10,967 sh (11.7% of target) | 94,005 sh | 188,009 sh (200%) | 2/3 ROE, 1/3 TSR; performance period 2024–2026 . |
Equity Ownership & Alignment
| Item | Value | Notes |
|---|---|---|
| Beneficial Common Stock | 2,688,836 sh | Includes 40,003 sh held by spouse and 156,251 sh in trusts . |
| Total Stock-Based Holdings (incl. RSUs, PSUs at target) | 3,201,552 sh | As of Mar 24, 2025 . |
| Options Exercisable within 60 Days | 2,281,500 sh | As of Mar 24, 2025 . |
| Unvested Performance Shares Outstanding | 328,005 sh at 200% (2023: 138,357; 2024: 189,648) | Payout value $20,747,491 at $109.40 stock price . |
| 2024 Option Exercises | 201,258 sh; $8,846,674 value realized | 2024 stock vesting: 137,460 sh; $15,508,231 value . |
| Ownership Guidelines | CEO 6× salary; met as of Mar 24, 2025 | Unvested PS counted at 50% of target; RSUs counted; options excluded . |
| Hedging/Pledging | Prohibited for Senior Executives | Robust insider trading policy; trades via 10b5-1 or windows . |
Notes on potential selling pressure:
- Upcoming PSU vest dates: 12/31/2025 (2023 grant) and 12/31/2026 (2024 grant); options continue to vest and have expirations laddered from 2026–2034 . Trading is constrained to windows or 10b5-1 plans; pledging is prohibited .
Employment Terms
| Provision | Terms | Notes |
|---|---|---|
| Employment Agreement | None (no individual agreements) | CEO governed by plans/policies. |
| Severance (not for cause) | 2× (base + target AIP), lump sum | Requires restrictive covenants . |
| Change-of-Control | Double trigger for cash severance (2× base + target AIP) and equity vesting if terminated without Cause or for Good Reason within 2 years post-CoC . | |
| AIP Treatment (termination) | Pro-rata for involuntary termination; retirement treatment if Rule of 65 met . | |
| Non-Compete/Non-Solicit | During employment and 1 year post-termination . | |
| Clawback | Comprehensive clawback policy (restatements and misconduct), updated Sept 2023 . | |
| Tax Gross-ups | None for perquisites or excise taxes on severance . | |
| Potential Payments (illustrative, as of 12/31/2024) | Involuntary not for cause: $42,478,127 total; CoC + termination: $42,478,127 total | Breakdowns include AIP, severance, accelerated equity, benefits . |
| Pension | PV of accumulated benefit: $88,029 (qualified) and $489,587 (excess); cash balance frozen since 2012 . | |
| Deferred Comp (Excess Savings Plan) | 2024 exec + company contributions $39,300 + $39,300; aggregate balance $2,105,091 . |
Board Governance
- Dual-role: CEO and Chairman are combined; all other directors are independent, with empowered Lead Director (Trevor Fetter) overseeing agendas, executive sessions, and performance evaluations; six executive sessions were held in 2024 without CEO present .
- Committees: Swift is a member of FIRMCo; key committees (Audit, Compensation, Nominating) are fully independent .
- Board activity and attendance: Board met six times in 2024; all directors attended ≥75% of meetings and the 2024 Annual Meeting .
- Director pay and independence: Employees are not paid for board service; director RSUs vest annually; directors have 5× retainer ownership guidelines and are subject to hedging/pledging prohibitions .
Compensation Structure Analysis
- Mix and metrics: CEO pay is ~93% variable with AIP tied to Compensation Core Earnings and LTI shifted in 2024 to 75% PSUs and 25% options, increasing ROE-linked PSU weighting to two-thirds (from 50%)—a stronger pay-for-performance tilt .
- Outcomes vs targets: 2024 AIP funded at 143% on $3.15B Compensation Core Earnings vs $2.84B target; 2022–2024 PSUs paid at 180% (ROE 200%, TSR 160%), signaling robust execution relative to long-term goals .
- Risk controls: Double-trigger equity for CoC, no re-pricing, no dividends on unvested awards/options, clawback, and no tax gross-ups; independent consultant (CAP) advises Compensation Committee .
- Shareholder support: Say-on-pay ~91% approval in 2024, reflecting investor endorsement of structure and outcomes .
Equity Ownership & Alignment (Policy Highlights)
- Ownership guideline: 6× salary for CEO; met as of Mar 24, 2025; retention of at least 50% of shares until compliant .
- Trading conduct: Strong insider trading policy; trades only through 10b5-1 plans or windows; company can suspend trading; hedging and pledging are prohibited .
- No related party transactions: None requiring review in 2024 .
Performance & Track Record
| Metric | 2024 | Commentary |
|---|---|---|
| Net Income ROE | 19.9% | Industry-leading, per proxy commentary . |
| Core Earnings ROE | 16.7% | Core measure used in compensation . |
| Net Income / Core Earnings | $3.1B / $3.1B | EPS $10.35 / $10.30 . |
| Revenues | $26.535B | SPGI-derived in peer table . |
| TSR (fixed $100 since 2019) | Company $202; Peer $201 | Outperformed peer index marginally . |
Board Service, Committee Roles, and Dual-Role Implications
- Board tenure and roles: Director since 2014; Chairman since 2015; member of FIRMCo; external public board (Citizens Financial Group) .
- Independence considerations: Board asserts optimality of combined CEO/Chairman given strong independent leadership; all other directors are independent; Lead Director controls agendas, information flow, and executive sessions, mitigating potential conflicts .
- Attendance and governance process: Six board meetings in 2024; rigorous annual/triannual evaluations; enhanced IT/cyber oversight and AI strategy reviews .
Investment Implications
- Pay-for-performance alignment appears strong: high variable mix, rigorous ROE/TSR metrics, and elevated PSU weighting drive shareholder value linkage; outcome history (AIP 143%, PSUs 180%) indicates disciplined execution .
- Retention risk is moderated by sizable unvested equity (multi-year PSUs and option ladders) and compliance with robust ownership guidelines; watch vest dates (12/31/2025, 12/31/2026) for potential transactional activity within policy constraints .
- Governance risk from combined CEO/Chairman role is mitigated by an empowered Lead Director and independent committees; say-on-pay support (~91%) suggests investor confidence in oversight and incentive design .
- Trading signals: Option exercises and PSU vestings can coincide with liquidity windows; while pledging is prohibited and trading is constrained to windows/10b5-1 plans, monitor scheduled vesting and option expirations as potential supply catalysts .